KURA•benzinga•
Kura Oncology, Kyowa Kirin Enter Global Strategic Collaboration To Develop And Commercialize Ziftomenib; Kura To Receive $330M Upfront Payment And Up To $1.2B In Total Milestone Payments
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 20, 2024 by benzinga